Tarsus Pharmaceuticals, Inc. Common Stock TARS
$74.29
-3.62%
at last close
Financials (TTM)
- Revenue
- $606.33 million
- Net Income
- $-46,476,000
- Net Margin
- -7.67%
- Return on Equity
- -13.40%
- Debt-to-Equity
- 0.21
- P/E Ratio
- —
- Price / Book
- 10.40
- Price / Sales
- 5.95
Over the trailing twelve months, Tarsus Pharmaceuticals, Inc. Common Stock generated revenue of $606.33 million and net income of $-46,476,000, a net margin of -7.67%.
At the last closing price of $74.29, TARS trades at 5.95 times sales, with a market capitalization of $3.61 billion.
Key Stats
- Last Close
- $74.29
- Market Cap
- $3.61 billion
- 52-Week Range
- $48.20 – $91.53
- Average Volume
- 730K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.